RAPT

RAPT Therapeutics, Inc.

7.02 USD
-18.95 (-72.97%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

RAPT Therapeutics, Inc. stock is down -71.43% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 4 February’s closed higher than January. In the last 7 Unusual Options Trades, there were 4 PUTs, 3 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
21 Dec 20:16 19 Jan, 2024 22.50 PUT 500 10
26 Dec 17:46 16 Feb, 2024 25.00 PUT 500 0
28 Dec 16:51 16 Feb, 2024 25.00 PUT 500 500
24 Jan 14:31 16 Aug, 2024 22.50 PUT 107 1550
08 Feb 15:28 17 May, 2024 30.00 CALL 110 50
08 Feb 15:28 16 Aug, 2024 35.00 CALL 30 234
20 Feb 19:26 16 Aug, 2024 10.00 CALL 1407 0

About RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc. focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

  • Evercore Partners
    Fri Feb 16, 07:53
    buy
    initial
  • Wolfe Research
    Thu Feb 15, 06:16
    buy
    initial